Alyeska Investment Group, L.P.

Position in ELAN — Elanco Animal Health Inc

CIK 1453072 CHICAGO, IL

Back to ELAN Full portfolio

Position in ELAN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$36,875,131

+$25,976,131 QoQ

Shares Held

1,498,380

+66.5% QoQ

Ownership

0.300%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#51

of 518 holders

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $270,329,085 across 4 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	6,257,579	$212,006,776
2	ELAN	Elanco Animal Health Inc This page	1,498,380	$36,875,131
3	AMLX	Amylyx Pharmaceuticals, Inc.	1,053,015	$18,912,149
4	RGC	Regencell Bioscience Holdings Ltd	416,261	$2,535,029

All Filings in ELAN

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,875,131	1,498,380	+66.5%	Shares	Sole	2026-08-14
2024-12-31	$10,899,000	900,000	-64.3%	Shares	Sole	2025-02-14
2024-09-30	$37,072,962	2,523,687	+89.9%	Shares	Sole	2024-11-14
2024-06-30	$19,172,650	1,328,666	+8.4%	Shares	Sole	2024-08-14
2024-03-31	$19,952,833	1,225,604	+411.1%	Shares	Sole	2024-05-15
2020-09-30	$6,697,027	239,779	-21.6%	Shares	Sole	2020-11-16
2020-06-30	$6,559,302	305,795	-84.6%	Shares	Sole	2020-08-14
2020-03-31	$44,469,786	1,986,145	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.